CClinicalTrials.gg
Active, not recruitingNCT07197346Updated Sep 21, 2026

Repetitive Transcranial Magnetic Stimulation Primed Self-controlled Practice on Motor Learning

An interventional study of rTMS - cTBS (Continuous Theta-Burst Stimulation) and Self-controlled (autonomy) in rTMS Stimulation, Autonomy and Healthy Young Adults, sponsored by National Taiwan University Hospital. Active, not recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Non-randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This study aims to investigate the additive effects of combining self-controlled practice with repetitive transcranial magnetic stimulation (rTMS) pretreatment on motivation enhancement and motor learning performance in healthy young adults. According to the "Optimizing Performance Through Intrinsic Motivation and Attention for Learning" (OPTIMAL) theory, numerous studies have demonstrated that providing learners with autonomy during practice can facilitate intrinsic motivation and motor learning. However, self-controlled practice alone may have limited effects, and further interventions may be required to amplify learning outcomes.

In recent years, non-invasive brain stimulation techniques-particularly high-frequency (facilitatory) rTMS applied to the dorsolateral prefrontal cortex (DLPFC)-have been shown to enhance motivational drive and explicit learning performance by strengthening the connectivity of the DLPFC-midbrain dopamine pathway. For example, 10 Hz high-frequency stimulation can significantly improve learners' accuracy and motivation. Interestingly, several sequence learning studies have found that low-frequency (inhibitory) rTMS, when used as a priming intervention, can instead enhance implicit procedural learning. This effect may occur because inhibiting the lateral prefrontal cortex reduces its top-down suppression of implicit learning systems, thereby releasing procedural learning potential.

Based on the theory of metaplasticity, applying facilitatory or inhibitory stimulation beforehand can alter the threshold of synaptic plasticity, thus influencing subsequent learning outcomes. Therefore, this study designed two DLPFC pretreatments-facilitatory and inhibitory-and combined them with self-controlled practice to systematically examine the interaction between different stimulation protocols on motivation and motor learning.

This cross-sectional experiment plans to recruit 72 healthy participants aged 20 or older, randomly assigned to one of six groups: (1) facilitatory rTMS + self-controlled practice, (2) facilitatory rTMS + yoked control, (3) inhibitory rTMS + self-controlled practice, (4) inhibitory rTMS + yoked control, (5) sham rTMS + self-controlled practice, and (6) sham rTMS + yoked control.

The experiment will last for seven days. On Day 1, participants will complete baseline testing, followed by facilitatory rTMS, inhibitory rTMS, or sham stimulation over the DLPFC. Immediately afterward, they will engage in a trajectory-tracking learning task (manipulating a joystick to reproduce a sine-wave pattern). After practice, participants will complete a motivation assessment. During the trajectory-tracking task, the self-controlled group can choose when to receive feedback to adjust their learning, whereas the yoked control group will receive feedback at time points matched to their paired counterpart.

On Day 2, participants will again receive the assigned rTMS (facilitatory, inhibitory, or sham), complete the trajectory-tracking task, and undergo a motivation assessment. After a five-minute rest, they will perform retention and transfer tests, followed by TMS measurement of cortical excitability. On Day 7, participants will return to the laboratory to complete another retention and transfer test, along with cortical excitability measurement via TMS.

The primary behavioral outcomes are the root mean square error (RMSE) and error estimation (EE) in the trajectory-tracking task. Motivation will be assessed using the Intrinsic Motivation Inventory (IMI). As there have been no prior studies combining DLPFC rTMS pretreatment with practice autonomy, the results of this experimental design are expected to provide new insights and references for enhancing motor learning ability in healthy adults.

02

Conditions studied

  • rTMS Stimulation
  • Autonomy
  • Healthy Young Adults

Keywords

  • motor learning
  • repetitive transcranial magnetic stimulation
  • autonomy
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Healthy adults aged 18-35 years
  2. Right-handed (per Edinburgh Handedness Inventory)
  3. Normal or corrected-to-normal vision and hearing
  4. Eligible for non-invasive brain stimulation per safety screening (no contraindications to TMS)
  5. Able to understand study procedures and provide written informed consent in Chinese
  6. Willing to comply with all study visits and tasks, including TBS/rTMS and motor practice
  7. For yoked pairing: able to be matched to a counterpart participant for practice parameters

Exclusion criteria

Exclusion Criteria:

  1. History of epilepsy, seizures, or unexplained fainting; family history of epilepsy in first-degree relatives
  2. Any intracranial metal or implanted medical devices (e.g., cochlear implant, deep brain stimulator, aneurysm clips); non-removable metallic objects in head/neck
  3. Cardiac pacemaker or other implanted electronic devices
  4. Current or past major neurological or psychiatric disorders (e.g., stroke, traumatic brain injury, multiple sclerosis, major depression, bipolar disorder, schizophrenia)
  5. Current use of medications lowering seizure threshold or affecting cortical excitability (e.g., tricyclic antidepressants, bupropion, clozapine, lithium, stimulant or sedative-hypnotic abuse); or unstable psychotropic regimens
  6. Active migraine with aura or chronic severe headaches
  7. Pregnancy or planning pregnancy during participation; breastfeeding (if your site policy excludes)
  8. Substance or alcohol use disorder within the past 12 months; positive alcohol/drug screen on visit days
  9. Sleep deprivation (\<5 hours) on the day before stimulation, or excessive caffeine (>400 mg) within 6 hours pre-stimulation
  10. Dermatologic conditions or open wounds at stimulation or EMG/electrode sites
  11. Prior extensive training on the specific motor task used in this study (risk of ceiling effects)
  12. Concurrent participation in another interventional study or received brain stimulation (TMS/tDCS) within the past 3 months
  13. Any condition that, in the investigator's judgment, makes participation unsafe or data unreliable
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    iTBS + autonomy

    Participants receive intermittent theta-burst stimulation (iTBS) as priming, followed by self-controlled practice of a joystick task. The participants will be able to self-select the trials for receiving feedback.

    Behavioral: Self-controlled (autonomy) · Device: rTMS- iTBS (Intermittent Theta-Burst Stimulation)

  • Active comparator
    iTBS + Yoked

    Participants receive iTBS priming, then perform motor practice with yoked (non-self-controlled) parameters matched to a self-controlled participant.

    Behavioral: Yoked Practice · Device: rTMS- iTBS (Intermittent Theta-Burst Stimulation)

  • Experimental
    cTBS + autonomy

    Participants receive continuous theta-burst stimulation (cTBS) as priming, followed by self-controlled practice of a joystick task. The participants will be able to self-select the trials for receiving feedback.

    Device: rTMS - cTBS (Continuous Theta-Burst Stimulation) · Behavioral: Self-controlled (autonomy)

  • Active comparator
    cTBS + Yoked

    Participants receive cTBS priming, then perform motor practice with yoked practice parameters.

    Device: rTMS - cTBS (Continuous Theta-Burst Stimulation) · Behavioral: Yoked Practice

  • Sham comparator
    Sham + autonomy

    Participants receive sham TBS stimulation as priming, followed by self-controlled practice of a joystick task. The participants will be able to self-select the trials for receiving feedback.

    Behavioral: Self-controlled (autonomy) · Device: Sham

  • Sham comparator
    Sham + Yoked

    Participants receive sham TBS priming, then perform motor practice with yoked parameters.

    Device: Sham · Behavioral: Yoked Practice

Interventions

  • DevicerTMS - cTBS (Continuous Theta-Burst Stimulation)

    Continuous theta-burst stimulation (cTBS) is a patterned form of rTMS consisting of bursts of three pulses at 50Hz, repeated every 200ms (5Hz), administered continuously without breaks. In this study, cTBS is delivered over the target cortical area according to established safety guidelines (e.g., a continuous 40s train for a total of 600 pulses) at an intensity set as a percentage of the resting motor threshold. The procedure is used to induce a transient reduction in cortical excitability as a priming intervention prior to motor practice.

  • BehavioralSelf-controlled (autonomy)

    Self-controlled practice is a motor learning intervention in which participants are granted autonomy to make choices about key aspects of their practice sessions (e.g., when to receive feedback, the sequence/timing of trials, or selection of specific practice parameters). This design allows participants to actively control elements of the training experience according to their preference, thereby fostering intrinsic motivation and engagement. The intervention is grounded in the OPTIMAL theory of motor learning, which highlights the role of autonomy support in enhancing learning outcomes and motivation. In this study, participants in the self-controlled practice group make their own decisions regarding practice conditions, in contrast to yoked controls who follow externally assigned parameters.

  • DeviceSham

    Sham TBS involves the application of a sham theta-burst stimulation protocol designed to mimic the sensory experience of active TBS without delivering effective magnetic pulses to the brain. This is typically achieved by angling the coil to prevent cortical stimulation. The procedure controls for placebo effects and participant expectations while ensuring blinding. The sham stimulation session matches the timing and setup of active TBS interventions but does not induce cortical excitability changes.

  • BehavioralYoked Practice

    Yoked practice refers to a motor learning protocol in which participants perform tasks under externally controlled practice conditions, matched to the parameters (e.g., feedback) of a paired participant from a self-controlled practice group. This design removes participant autonomy over practice choices, allowing comparison between self-controlled and externally controlled practice to evaluate the effects of autonomy on motor learning and motivation.

  • DevicerTMS- iTBS (Intermittent Theta-Burst Stimulation)

    Intermittent theta-burst stimulation (iTBS) is a patterned form of repetitive transcranial magnetic stimulation (rTMS) consisting of bursts of three pulses at 50Hz, repeated every 200ms (5Hz). In this study, iTBS is delivered over the target cortical area using standard protocols (e.g., 2s trains of TBS repeated every 10s for a total of 600 pulses) at an intensity set as a percentage of the resting motor threshold. The procedure aims to facilitate cortical excitability as a priming intervention prior to motor practice.

06

What researchers measure

Primary outcomes

  1. Change in Motor Task Accuracy (Root Mean Square Error, RMSE)

    Root Mean Square Error (RMSE) on the target motor task, computed across trials within each assessment block to quantify spatial/temporal accuracy. RMSE is calculated as the square root of the mean of squared deviations between the participant's performance trajectory/output and the predefined target/ideal trajectory/output. Lower RMSE indicates better accuracy. The primary endpoint is the change from baseline, defined as RMSE at the post-practice assessment minus RMSE at baseline. If multiple trials are collected per block, RMSE will be averaged across trials to yield a single value per time point. Outliers and artifact-contaminated trials will be handled according to a prespecified quality-control procedure \[e.g., exclude trials with \>3 SD from block mean or device-detected artifacts\], and the number of excluded trials will be recorded.

    Time frame: Throughout practice on Day1 and Day2, immediately post-practice on Day2, and at the retention and transfer tests on Day 7.

Secondary outcomes

  1. Intrinsic Motivation Inventory (IMI)

    Total IMI score assessing task-related intrinsic motivation (e.g., interest/enjoyment, perceived competence, effort/importance, perceived choice). Specify version, item count, and response scale (e.g., 1-7 Likert). Higher scores indicate higher intrinsic motivation.

    Time frame: Immediately post-practice on Day 1 and Day 2

  2. Change in Corticospinal Excitability/Inhibition

    We record Motor Evoked Potential (MEP) Amplitude, Resting and Active Motor Thresholds, Cortical Silent Period (CSP), and Short-Interval Intracortical Inhibition (SICI) via TMS. Resting motor threshold (RMT) and active motor threshold (AMT) determined via standard procedures to anchor stimulation intensities. Peak-to-peak MEP amplitude recorded from the target muscle using single-pulse TMS at fixed intensity relative to resting motor threshold (e.g., 120% RMT). CSP duration measured during tonic contraction using suprathreshold single-pulse TMS. Longer CSP reflects stronger GABA-B-mediated inhibition. Paired-pulse TMS determines SICI with a subthreshold conditioning stimulus followed by a suprathreshold test stimulus at a short interstimulus interval (e.g., 2-3ms). Lower conditioned/test ratio indicates stronger GABA-A-mediated inhibition.

    Time frame: At baseline before priming, immediately post-practice on Day 2, and on Day 7

  3. Change in Error Estimation Accuracy (EE)

    Subjective estimation of own motor performance error recorded after each trial/block. EE accuracy is defined as the absolute difference between the participant's estimated error and the actual task error (e.g., RMSE) for the same trial/block. Lower values indicate more accurate metacognitive estimation. Outcome is the change from baseline calibration to post-practice.

    Time frame: Post-practice on Day 2, and after tests on Day7

07

Study locations

1 site
  • School and Graduate Institute of Physical Therapy
    Taipei, 100, Taiwan
08

References and documents

Individual participant data

Plan to share: Yes — The IPD collected in this study will be available to other researchers upon reasonable request to the principal investigator after the study has been completed.

Supporting information: Study protocol, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07197346
Lead sponsor
National Taiwan University Hospital
Collaborators
National Science and Technology Council, Taiwan
Responsible party
Sponsor
First posted
Sep 29, 2025
Start date
Sep 1, 2025
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Sep 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion